Flunarizine
- Generic Name
- Flunarizine
- Drug Type
- Small Molecule
- Chemical Formula
- C26H26F2N2
- CAS Number
- 52468-60-7
- Unique Ingredient Identifier
- R7PLA2DM0J
- Background
Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.
- Indication
Used in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.
- Associated Conditions
- Severe Migraine
Study of Key Electro-acupuncture Technique on Migraine
Not Applicable
Completed
- Conditions
- Migraine
- Interventions
- Device: electro-acupuncture
- First Posted Date
- 2015-10-20
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Shanghai University of Traditional Chinese Medicine
- Target Recruit Count
- 2
- Registration Number
- NCT02580968
- Locations
- 🇨🇳
Longhua Hospital,Shanghai University of Traditional Chinese Medicine, Shanghai, China
A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or Separately
Phase 1
Completed
- Conditions
- Human VolunteersMigraine
- First Posted Date
- 2008-09-15
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 75
- Registration Number
- NCT00752466
Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol
Phase 4
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2008-08-22
- Last Posted Date
- 2008-08-22
- Lead Sponsor
- Ambulatório de Bipolaridade
- Target Recruit Count
- 70
- Registration Number
- NCT00740259
- Locations
- 🇧🇷
Universidade Federal de São Paulo, São Paulo, SP, Brazil
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath